Elanco Animal Health Inc [NYSE: ELAN] stock went on a downward path that fall over -4.95% on Wednesday, amounting to a one-week price decrease of less than -9.12%.
Over the last 12 months, ELAN stock rose by 38.41%. The one-year Elanco Animal Health Inc stock forecast points to a potential upside of 29.84. The average equity rating for ELAN stock is currently 1.86, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $6.55 billion, with 492.85 million shares outstanding and 488.20 million shares in the current float. Compared to the average trading volume of 4.79M shares, ELAN stock reached a trading volume of 8988106 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Elanco Animal Health Inc [ELAN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $18.90 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 1.86. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Elanco Animal Health Inc shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on September 19, 2024. While these analysts kept the previous recommendation, Stifel raised their target price from $13 to $20. The new note on the price target was released on January 05, 2024, representing the official price target for Elanco Animal Health Inc stock. Previously, the target price had yet another raise to $17, while Jefferies analysts kept a Buy rating on ELAN stock.
The Average True Range (ATR) for Elanco Animal Health Inc is set at 0.54, with the Price to Sales ratio for ELAN stock in the period of the last 12 months amounting to 1.46. The Price to Book ratio for the last quarter was 1.10, with the Price to Cash per share for the same quarter was set at 0.84. Price to Free Cash Flow for ELAN in the course of the last twelve months was 15.42 with Quick ratio for the last quarter at 1.75.
ELAN Stock Performance Analysis:
Elanco Animal Health Inc [ELAN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.12. With this latest performance, ELAN shares dropped by -7.21% in over the last four-week period, additionally sinking by -1.12% over the last 6 months – not to mention a rise of 38.41% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ELAN stock in for the last two-week period is set at 33.59, with the RSI for the last a single of trading hit 24.98, and the three-weeks RSI is set at 38.54 for Elanco Animal Health Inc [ELAN]. The present Moving Average for the last 50 days of trading for this stock 14.41, while it was recorded at 14.09 for the last single week of trading, and 15.12 for the last 200 days.
Insight into Elanco Animal Health Inc Fundamentals:
Elanco Animal Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.75 and a Current Ratio set at 2.93.
ELAN Stock EPS
With the latest financial reports released by the company, Elanco Animal Health Inc posted 0.18/share EPS, while the average EPS was predicted by analysts to be reported at 0.12/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.06. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Inc go to 10.47%.
Elanco Animal Health Inc [ELAN] Institutonal Ownership Details
There are presently around $99.13%, or 99.79%% of ELAN stock, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: DODGE & COX with ownership of 83.58 million shares, which is approximately 16.9471%. PRIMECAP MANAGEMENT CO/CA/, holding 52.8 million shares of the stock with an approximate value of $$761.94 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $$713.53 million in ELAN stock with ownership which is approximately 10.0259%.
